UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Sei Investments Co.

Sei Investments Co. trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 11.0% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 418,637 shares of the healthcare conglomerate’s stock after selling 51,658 shares during the period. Sei Investments Co.’s holdings in UnitedHealth Group were worth $211,775,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. Plancorp LLC grew its stake in UnitedHealth Group by 15.4% in the fourth quarter. Plancorp LLC now owns 12,805 shares of the healthcare conglomerate’s stock worth $6,478,000 after purchasing an additional 1,711 shares in the last quarter. Runnymede Capital Advisors Inc. bought a new position in UnitedHealth Group in the fourth quarter worth about $70,000. Cyrus J. Lawrence LLC lifted its holdings in UnitedHealth Group by 5.2% in the fourth quarter. Cyrus J. Lawrence LLC now owns 611 shares of the healthcare conglomerate’s stock worth $309,000 after acquiring an additional 30 shares during the last quarter. Mizuho Securities USA LLC lifted its holdings in UnitedHealth Group by 45.7% in the fourth quarter. Mizuho Securities USA LLC now owns 87,222 shares of the healthcare conglomerate’s stock worth $44,122,000 after acquiring an additional 27,343 shares during the last quarter. Finally, ZEGA Investments LLC bought a new position in UnitedHealth Group in the fourth quarter worth about $5,358,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on UNH shares. Piper Sandler cut their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. Stephens upped their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $629.32.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $517.72 on Friday. The company’s fifty day moving average is $510.19 and its two-hundred day moving average is $547.47. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a market cap of $473.57 billion, a P/E ratio of 33.40, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the business earned $5.83 EPS. The company’s revenue was up 6.8% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.62%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.